Literature DB >> 11093138

Human T cells elicit IFN-alpha secretion from dendritic cells following cell to cell interactions.

G R Foster1, C Germain, M Jones, R I Lechler, G Lombardi.   

Abstract

Major insights into events that control Th1/Th2 differentiation have been acquired recently, and highlight the role of Type I IFN in Th1 generation, by inducing up-regulation of the IL-12 receptor beta(2) subunit. IFN-alpha induces responsiveness to IL-12, and here we have investigated the source and the circumstances under which IFN-alpha is produced, in the absence of viral infections. Human dendritic cells (DC) were co-cultured with autologous T cells activated by cross-linking the CD3 complex. DC were also cultured with L cells expressing human CD40 ligand (CD40L). Our results show that large amounts (>200 IU IFN-alpha from 2.5x10(4) cells) of IFN-alpha are produced by DC following interaction with stimulated T cells. Similar effects were observed when DC were cultured with CD40L-expressing transfectants, although the amount of IFN-alpha produced was reduced, suggesting that the CD40-CD40L interaction may be important. These results show that stimulated T cells can solicit the signals from DC that allow their polarization towards a Th1 phenotype. Type I DC produce Type I IFN not only following viral infection but also during an immunological interaction and this may be the basic mechanism that assists in the development of a Th1 response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093138     DOI: 10.1002/1521-4141(200011)30:11<3228::AID-IMMU3228>3.0.CO;2-B

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.

Authors:  A Tamir; W J Jordan; M Ritter; N Habib; R I Lechler; G R Foster; G Lombardi
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens.

Authors:  Karen Scott; Maria Manunta; Conrad Germain; Peter Smith; Meleri Jones; Peter Mitchell; Daniele Dessi; Kathleen Branigan Bamford; Robert I Lechler; Pier Luigi Fiori; Graham R Foster; Giovanna Lombardi
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 3.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.

Authors:  Amy D Brideau-Andersen; Xiaojian Huang; Siu-Chi Chang Sun; Teddy T Chen; Diane Stark; Ian J Sas; Linda Zadik; Glenn N Dawes; Douglas R Guptill; Robert McCord; Sridhar Govindarajan; Ajoy Roy; Shumin Yang; Judy Gao; Yong Hong Chen; Niels Jørgen Ø Skartved; Annette K Pedersen; David Lin; Christopher P Locher; Indrani Rebbapragada; Anne Dam Jensen; Steven H Bass; Torben L Straight Nissen; Sridhar Viswanathan; Graham R Foster; Julian A Symons; Phillip A Patten
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

5.  IFN-α is constitutively expressed in the human thymus, but not in peripheral lymphoid organs.

Authors:  Arnaud D Colantonio; Marta Epeldegui; Maria Jesiak; Loes Jachimowski; Bianca Blom; Christel H Uittenbogaart
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

6.  The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen.

Authors:  Pauline Sebby Ogolla; Jose-Andres C Portillo; Christine L White; Krupen Patel; Bruce Lamb; Ganes C Sen; Carlos S Subauste
Journal:  PLoS Pathog       Date:  2013-08-22       Impact factor: 6.823

7.  Involvement of dendritic cells in autoimmune diseases in children.

Authors:  Consuelo M López de Padilla; Ann M Reed
Journal:  Pediatr Rheumatol Online J       Date:  2007-07-11       Impact factor: 3.054

8.  A Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic Modeling.

Authors:  Z Li; H Zhou; Y Lu; T Colatsky
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.